Form 4 · Filed Jun 2, 2026, 08:05 PM UTC
GLUE/Monte Rosa Therapeutics, Inc.
Warmuth Markus — President & CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | S | sell | 4,998 | $19 | $97,021 | 595,006 |
| Jun 1, 2026 | S | sell | 468 | $20 | $9,232 | 594,538 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-253472